DPM2 Gene Glycosylation Disorder Type 1U Genetic Test
Welcome to DNA Labs UAE, where we offer comprehensive genetic testing services. Today, we will be discussing the DPM2 gene glycosylation disorder type 1U genetic test.
Test Details
The DPM2 gene is responsible for encoding the dolichyl-phosphate mannosyltransferase subunit 2 protein, which plays a crucial role in the glycosylation process. Glycosylation is the process of attaching sugar molecules to proteins or lipids, and it is essential for proper protein folding, stability, and function.
A glycosylation disorder occurs when there is a mutation or alteration in the genes involved in glycosylation, leading to abnormal glycosylation patterns. DPM2 gene glycosylation disorder type 1U is a specific subtype of glycosylation disorder caused by mutations in the DPM2 gene.
Test Method
To diagnose DPM2 gene glycosylation disorder type 1U, a Next-Generation Sequencing (NGS) genetic test can be performed. NGS is a high-throughput DNA sequencing technology that allows for the simultaneous analysis of multiple genes. It can identify mutations or alterations in the DPM2 gene, which can help confirm the diagnosis of DPM2 gene glycosylation disorder type 1U.
NGS genetic testing involves obtaining a DNA sample, typically through a blood sample, and sequencing the DNA to identify any genetic variations. The DNA sequence data is then compared to a reference sequence to identify any mutations or alterations in the DPM2 gene associated with glycosylation disorder type 1U.
Test Components and Price
- Test Name: DPM2 Gene Glycosylation Disorder Type 1U Genetic Test
- Components: NGS Technology
- Price: 4400.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Test Type: Metabolic Disorders
- Doctor: General Physician
- Test Department: Genetics
- Pre Test Information: Clinical History of Patient who is going for DPM2 Gene Glycosylation Disorder Type 1U NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with Glycosylation Disorder Type 1U
Importance of the Test
The results of the NGS genetic test can provide valuable information for diagnosis, prognosis, and potential treatment options for individuals with DPM2 gene glycosylation disorder type 1U. It can also help in genetic counseling for affected individuals and their families.
At DNA Labs UAE, we strive to provide accurate and reliable genetic testing services. If you suspect that you or a family member may have DPM2 gene glycosylation disorder type 1U, we encourage you to consult with a general physician and consider undergoing our DPM2 Gene Glycosylation Disorder Type 1U Genetic Test.
For more information or to schedule an appointment, please contact us at [insert contact details].
| Test Name | DPM2 Gene Glycosylation disorder type 1U Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Metabolic Disorders |
| Doctor | General Physician |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for DPM2 Gene Glycosylation disorder type 1U NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Glycosylation disorder type 1U |
| Test Details |
The DPM2 gene is responsible for encoding the dolichyl-phosphate mannosyltransferase subunit 2 protein, which plays a crucial role in the glycosylation process. Glycosylation is the process of attaching sugar molecules to proteins or lipids, and it is essential for proper protein folding, stability, and function. A glycosylation disorder occurs when there is a mutation or alteration in the genes involved in glycosylation, leading to abnormal glycosylation patterns. DPM2 gene glycosylation disorder type 1U is a specific subtype of glycosylation disorder caused by mutations in the DPM2 gene. To diagnose DPM2 gene glycosylation disorder type 1U, a Next-Generation Sequencing (NGS) genetic test can be performed. NGS is a high-throughput DNA sequencing technology that allows for the simultaneous analysis of multiple genes. It can identify mutations or alterations in the DPM2 gene, which can help confirm the diagnosis of DPM2 gene glycosylation disorder type 1U. NGS genetic testing involves obtaining a DNA sample, typically through a blood sample, and sequencing the DNA to identify any genetic variations. The DNA sequence data is then compared to a reference sequence to identify any mutations or alterations in the DPM2 gene associated with glycosylation disorder type 1U. The results of the NGS genetic test can provide valuable information for diagnosis, prognosis, and potential treatment options for individuals with DPM2 gene glycosylation disorder type 1U. It can also help in genetic counseling for affected individuals and their families. |
